Learning Objectives:

•Apply the 2026 International Olympic Committee Consensus guidance to your screening, surveillance and treatment of common mental health symptoms and disorders in elite athletes

•Describe stressors and environmental factors that impact elite athlete mental health

•Explain the need for more research on the mental health of elite athletes, especially Para athletes and adolescent athletes

•Identify common injectable peptides marketed to athletes for recovery and performance enhancement.

•Explain the current lack of evidence to support the use of these peptides by athletes desiring to optimize recovery and sport performance

•Summarize sports medicine physician perception of GLP-1 RA use by competitive athletes

•Compare the risk/benefit of GLP-1 RA drug effects that offer theoretical performance-enhancing potential 

Session date: 
02/27/2026 - 7:00am to 7:45am CST
Location: 
In-person and Virtually
621 Science Dr | 4602 Eastpark Blvd | East Madison Hospital
Madison, WI 53711 | 53718
United States
  • 0.75 AMA PRA Category 1 Credit
  • 0.75 BOC Category A CEUs
  • 0.75 Physical Therapy Contact Hours
  • 0.75 University of Wisconsin–Madison Continuing Education Hours
    • 0.75 Approved for AMA PRA Category 1 Credit™
Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Dr. Kathleen Carr